Symbicort Aerosol
NDC Package 50090-4510-0
Package Information
Symbicort (budesonide and formoterol fumarate dihydrate) aerosols is the use of SYMBICORT is contraindicated in the following conditions: •Primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required. This formulation utilizes a aerosol delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-4510 and is authorized under FDA application NDA021929.
Identification & Billing
- RxCUI: 1246314 - budesonide/formoterol fumarate 80/4.5 MCG/INHAL Metered Dose Inhaler, 60 Actuations
- RxCUI: 1246314 - 60 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 1246314 - budesonide 0.08 MG / formoterol fumarate 0.0045 MG per ACTUAT Metered Dose Inhaler, 60 ACTUAT
- RxCUI: 1246314 - budesonide 80 MCG / formoterol fumarate 4.5 MCG per ACTUAT Metered Dose Inhaler, 60 ACTUAT
- RxCUI: 1246315 - Symbicort 80/4.5 MCG/INHAL Metered Dose Inhaler, 60 Actuations
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-4510 - Symbicort
- 50090-4510-0 - 1 POUCH in 1 CARTON / 1 AEROSOL in 1 POUCH
- 50090-4510 - Symbicort
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-4510-0 identifies a specific commercial package of 1 pouch in 1 carton / 1 aerosol in 1 pouch of Symbicort, a human prescription drug labeled by A-s Medication Solutions. This aerosol is formulated for respiratory (inhalation) use and contains budesonide; formoterol fumarate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on May 29, 2007. The current certification is valid through December 31, 2026.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090451000. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.